Axion BioSystems Continues Agreement Giving Corning® Exclusive Rights to Distribute Award-Winning Cell Counting Device
Axion BioSystems has extended its agreement with Corning Incorporated (NYSE: GLW) for exclusive worldwide distribution rights of the Corning® Cell Counter. This device, developed by Axion and distributed by Corning, was recently recognized in the SelectScience® top 10 list of products advancing life science research. The cell counter offers superior speed and reproducibility compared to manual counting, with the ability to distinguish between cells and debris, detect individual cells in clusters, and count 3D organoids.
The agreement aims to continue bringing essential, affordable lab tools to market and accelerate discovery. Axion BioSystems CEO Julien Bradley highlighted the device's benefits in simplifying workflows, saving time, and improving reliability in cell culture laboratories.
Axion BioSystems ha esteso il suo accordo con Corning Incorporated (NYSE: GLW) per i diritti di distribuzione esclusiva a livello mondiale del Corning® Cell Counter. Questo dispositivo, sviluppato da Axion e distribuito da Corning, è stato recentemente riconosciuto nella top 10 di SelectScience® dei prodotti che avanzano la ricerca nelle scienze della vita. Il contatore di cellule offre superiore velocità e riproducibilità rispetto al conteggio manuale, con la capacità di distinguere tra cellule e detriti, rilevare cellule individuali in gruppi e contare organoidi 3D.
L'accordo ha come obiettivo quello di continuare a portare sul mercato strumenti di laboratorio essenziali e abbordabili e accelerare la scoperta. Il CEO di Axion BioSystems, Julien Bradley, ha evidenziato i vantaggi del dispositivo nella semplificazione dei flussi di lavoro, nel risparmio di tempo e nel miglioramento dell'affidabilità nei laboratori di coltura cellulare.
Axion BioSystems ha ampliado su acuerdo con Corning Incorporated (NYSE: GLW) para los derechos de distribución exclusivos a nivel mundial del Corning® Cell Counter. Este dispositivo, desarrollado por Axion y distribuido por Corning, fue recientemente reconocido en la lista top 10 de SelectScience® de productos que avanzan la investigación en ciencias de la vida. El contador de células ofrece superior velocidad y reproducibilidad en comparación con el conteo manual, con la capacidad de distinguir entre células y residuos, detectar células individuales en grupos y contar organoides 3D.
El acuerdo tiene como objetivo seguir ofreciendo herramientas de laboratorio esenciales y asequibles y acelerar el descubrimiento. El CEO de Axion BioSystems, Julien Bradley, destacó los beneficios del dispositivo al simplificar los flujos de trabajo, ahorrar tiempo y mejorar la confiabilidad en los laboratorios de cultivo celular.
Axion BioSystems는 Corning Incorporated (NYSE: GLW)와 Corning® Cell Counter의 전 세계 독점 배급권을 위한 계약을 연장했습니다. Axion이 개발하고 Corning이 배급하는 이 장치는 최근 SelectScience®의 top 10 목록에서 생명 과학 연구를 촉진하는 제품으로 인정받았습니다. 세포 카운터는 수동 계산에 비해 우수한 속도와 재현성을 제공하며, 세포와 잔여물을 구별하고, 클러스터 내 개별 세포를 감지하며, 3D 오르가노이드를 계산할 수 있는 기능을 가지고 있습니다.
이 계약은 필수적이고 저렴한 실험실 도구를 시장에 계속 공급하고 발견을 가속화하는 것을 목표로 하고 있습니다. Axion BioSystems의 CEO인 Julien Bradley는 이 장치가 작업 흐름을 간소화하고, 시간을 절약하며, 세포 배양 실험실에서의 신뢰성을 개선하는 데 기여한다고 강조했습니다.
Axion BioSystems a étendu son accord avec Corning Incorporated (NYSE: GLW) pour les droits de distribution exclusifs à l'échelle mondiale du Corning® Cell Counter. Cet appareil, développé par Axion et distribué par Corning, a récemment été reconnu dans la liste des 10 meilleurs de SelectScience® des produits qui font progresser la recherche en sciences de la vie. Le compteur de cellules offre une vitesse et une reproductibilité supérieures par rapport au comptage manuel, avec la capacité de distinguer les cellules des débris, de détecter des cellules individuelles dans des groupes et de compter des organoïdes 3D.
Cette accord vise à continuer à proposer des outils de laboratoire essentiels et abordables sur le marché et à accélérer la découverte. Julien Bradley, le PDG d'Axion BioSystems, a souligné les avantages de cet appareil pour simplifier les flux de travail, gagner du temps et améliorer la fiabilité dans les laboratoires de culture cellulaire.
Axion BioSystems hat seine Vereinbarung mit Corning Incorporated (NYSE: GLW) um die exklusiven Vertriebsrechte für den Corning® Cell Counter weltweit erweitert. Dieses Gerät, das von Axion entwickelt und von Corning vertrieben wird, wurde kürzlich in der Top 10-Liste von SelectScience® als Produkt zur Förderung der Lebenswissenschaften anerkannt. Der Zellzähler bietet überlegene Geschwindigkeit und Reproduzierbarkeit im Vergleich zur manuellen Zählung, mit der Fähigkeit, zwischen Zellen und Ablagerungen zu unterscheiden, Einzelzellen in Clustern zu erkennen und 3D-Organoide zu zählen.
Das Ziel der Vereinbarung ist es, weiterhin unentbehrliche, erschwingliche Laborinstrumente auf den Markt zu bringen und die Entdeckung zu beschleunigen. Der CEO von Axion BioSystems, Julien Bradley, hob die Vorteile des Geräts hervor, die Arbeitsabläufe zu vereinfachen, Zeit zu sparen und die Zuverlässigkeit in Zellkultur-Laboren zu verbessern.
- Exclusive worldwide distribution agreement with Corning Incorporated (NYSE: GLW)
- Corning Cell Counter recognized in SelectScience® top 10 list of products advancing life science research
- Cell counter offers superior speed and reproducibility compared to manual counting
- Device can distinguish between cells and debris, detect individual cells in clusters, and count 3D organoids
- None.
The simple yet powerful Corning Cell Counter is an automated cell counting platform designed for biomedical research. (Photo: Business Wire)
Cell counting is a critical step in biomedical research applications, clinical diagnostics, and cell therapy administration. Compared to tedious and time-consuming manual cell counting, the Corning Cell Counter offers superior speed and reproducibility and an unprecedented level of detail, allowing it to distinguish between cells and debris, detect individual cells within a cluster, or count three-dimensional organoids and measure their size.
“The Corning Cell Counter not only simplifies the workflow in cell culture laboratories but is also timesaving and more reliable than standard methods,” said Axion BioSystems CEO Julien Bradley. “We look forward to extending our successful collaboration with Corning to distribute Axion’s cell counting device to scientists worldwide working to unlock the mechanisms of disease and accelerate the development of groundbreaking therapeutics.”
Since launching the revolutionary Maestro multielectrode array (MEA) platform in 2008, Axion BioSystems has continuously expanded its line of next-generation live-cell analysis tools to meet the demands of today’s complex research. In addition to next-generation MEA systems and cell counters, the company’s portfolio also includes impedance-based analyzers, automated imaging systems, and high-quality consumables used in academic, pharmaceutical, and biotech labs around the world.
About Axion BioSystems
Axion BioSystems is a leading life sciences tools company focused on innovative live-cell assays used to study the function of cells in vitro for drug discovery and disease modeling. The team at Axion BioSystems is dedicated to continuing the advancement of new technologies that accelerate research and further the understanding of biological complexity outside of the body. Axion BioSystems is headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20240807412467/en/
Mike Clements
SVP Marketing & Corporate Strategy, Axion BioSystems
+1-678-469-3439
mclements@axionbio.com
Source: Axion BioSystems
FAQ
What is the distribution agreement between Axion BioSystems and Corning for the Corning Cell Counter?
What recognition did the Corning Cell Counter receive recently?
What are the key advantages of the Corning Cell Counter over manual cell counting?
How does the Corning Cell Counter benefit cell culture laboratories according to Axion BioSystems' CEO?
